Antiviral Drugs - Pakistan

Pakistan

Pakistan is set to experience significant growth in the Antiviral Drugs market.
With revenue projected to reach US$42.35m in 2024, the country is expected to witness a steady annual growth rate (CAGR 2024-2028) of 0.08%.
This growth trajectory will lead to a market volume of US$42.48m by 2028.
In comparison to other countries, United States will continue to dominate the global Antiviral Drugs market, with revenue estimated to reach a staggering US$32,110.00m in 2024.
However, Pakistan's market potential should not be underestimated as it demonstrates promising growth prospects within this market.
Pakistan's pharmaceutical industry is experiencing a surge in demand for antiviral drugs, driven by the country's efforts to combat infectious diseases.

Key regions: France, Brazil, South Korea, India, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Antiviral Drugs market in Pakistan has seen significant growth in recent years.

Customer preferences: Customers in Pakistan are increasingly seeking out antiviral drugs due to the rising incidence of viral infections in the country. The COVID-19 pandemic has also contributed to the increased demand for antiviral drugs, as people seek to protect themselves from the virus.

Trends in the market: One of the key trends in the Antiviral Drugs market in Pakistan is the increasing availability of generic antiviral drugs. This has made antiviral drugs more affordable and accessible to a wider range of customers. Additionally, there has been a growing focus on developing antiviral drugs that are more effective against a broader range of viruses.

Local special circumstances: Pakistan has a high incidence of viral infections, which has contributed to the growth of the Antiviral Drugs market in the country. Additionally, the country has a large population, which means that there is a significant potential market for antiviral drugs.

Underlying macroeconomic factors: The Pakistani economy has been growing steadily in recent years, which has contributed to the growth of the Antiviral Drugs market. Additionally, the government has been investing in healthcare infrastructure, which has helped to improve access to healthcare services across the country. Overall, these factors are likely to continue to drive growth in the Antiviral Drugs market in Pakistan in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.